 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | 211At-OKT10-B10 / Fred Hutchinson Cancer Center
Enrollment change, Trial withdrawal: Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma (clinicaltrials.gov) - Feb 15, 2024
P1, N=0, Withdrawn, Sponsor: Fred Hutchinson Cancer Center
N=30 --> 0 | Recruiting --> Withdrawn
- | 211At-OKT10-B10 / Fred Hutchinson Cancer Center
Enrollment open, Trial completion date, Trial primary completion date: Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma (clinicaltrials.gov) - Sep 15, 2023
P1, N=30, Recruiting, Sponsor: Fred Hutchinson Cancer Center
N=30 --> 0 | Recruiting --> Withdrawn Withdrawn --> Recruiting | Trial completion date: Mar 2026 --> Sep 2027 | Trial primary completion date: Mar 2024 --> Oct 2025
- | 211At-OKT10-B10 / Fred Hutchinson Cancer Center
Enrollment change, Trial withdrawal: Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma (clinicaltrials.gov) - Sep 1, 2023
P1, N=0, Withdrawn, Sponsor: Fred Hutchinson Cancer Center
Withdrawn --> Recruiting | Trial completion date: Mar 2026 --> Sep 2027 | Trial primary completion date: Mar 2024 --> Oct 2025 N=30 --> 0 | Recruiting-> Withdrawn
- | 211At-OKT10-B10 / Fred Hutchinson Cancer Center
Enrollment open: Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma (clinicaltrials.gov) - Jul 28, 2022
P1, N=24, Recruiting, Sponsor: Fred Hutchinson Cancer Center
N=30 --> 0 | Recruiting-> Withdrawn Not yet recruiting --> Recruiting
- | 211At-OKT10-B10 / Fred Hutchinson Cancer Center
Trial initiation date: Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma (clinicaltrials.gov) - Jun 3, 2021
P1, N=25, Not yet recruiting, Sponsor: Fred Hutchinson Cancer Research Center
Not yet recruiting --> Recruiting Initiation date: Jun 2021 --> Sep 2021
- | 211At-OKT10-B10 / Fred Hutchinson Cancer Center
Trial initiation date: Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma (clinicaltrials.gov) - Mar 10, 2021
P1, N=25, Not yet recruiting, Sponsor: Fred Hutchinson Cancer Research Center
Initiation date: Jun 2021 --> Sep 2021 Initiation date: Mar 2021 --> Jun 2021
- | 211At-OKT10-B10 / Fred Hutchinson Cancer Center
Trial initiation date: Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma (clinicaltrials.gov) - Dec 1, 2020
P1, N=25, Not yet recruiting, Sponsor: Fred Hutchinson Cancer Research Center
Initiation date: Mar 2021 --> Jun 2021 Initiation date: Nov 2020 --> Mar 2021
- | 211At-OKT10-B10 / Fred Hutchinson Cancer Center
New P1 trial, Combination therapy: (clinicaltrials.gov) - Oct 7, 2020
P1, N=30, Not yet recruiting, Sponsor: Fred Hutchinson Cancer Research Center
- | 211At-OKT10-B10 / Fred Hutchinson Cancer Center
New P1 trial: Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma (clinicaltrials.gov) - Jul 10, 2020
P1, N=25, Not yet recruiting, Sponsor: Fred Hutchinson Cancer Research Center